Page 17 - Pharma Stocks

Alembic Pharma slips 5%; board approves Rs 1,150 cr as impairment charges

This one time impairment impact notwithstanding, we believe this move bodes well for future return ratios and profitability. We expect more impairments in due course, ICICI Securities said in a note.

Analysts turn cautious on Cipla as US FDA action delays key US launches

Analysts believe that some of the recent observations from the US FDA are critical in nature and could lead to a potential Official Action Indicated (OAI) classification for the Indore plant

This beaten down pharma stock has zoomed over 50% in last 11 trading days

Shares of Dishman Carbogen Amcis zoomed 14 per cent to Rs 124 on the BSE in Tuesday's intra-day trade on the back of heavy volumes

Nifty Pharma dips to 7-mth low; bears may gain control if breaks 52-wk low

Barring Sun Pharmaceutical Industries, which is anticipated to rally up to 10 per cent; other stocks indicate weak bias, as per technical charts

Cipla dips 7% after Pithampur unit receives 8 USFDA observations

The company said it will work closely with the USFDA and is committed to address these comprehensively within stipulated time.

Natco Pharma jumps 4% on filing generic version of oncology drug in US

The drug major filed an abbreviated new drug application (ANDA) for generic versions of Olaparib tablets - 100 mg and 150 mg with the US Food and Drug Administration (USFDA)

Glenmark Pharma jumps 5% post December quarter earnings

The company reported a 21 per cent surge in Q3 consolidated net at Rs 291 crore.

Sun Pharma nears 52-week high ahead of Q3 results; stock up 7% in a month

In the past one month, Sun Pharma outperformed market as shares surged 7 per cent, as compared to 2.5 per cent decline in the S&P BSE Sensex

Stocks to Watch: TCS, Paytm, PTC, Lodha, Heritage Foods, Electronics Mart

Stocks to Watch: TCS and other IT stocks in focus, as the Tata Group IT major will be reporting its Q3 earnings on Monday.

Stocks to Watch: Elin Electronics, Cipla, Eicher Motors, RIL, Banks, Pharma

Stocks to Watch: Elin Electronics to debut today, the stock is likely to list on a quiet note.

Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%

Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.

Stock of this PSU pharma company has zoomed 61% in 3 days on heavy volumes

The stock was locked in the 20% upper circuit; around 1.4 million shares, representing 3.2 per cent of total equity of the pharmaceutical company, changed hands on bourses

Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains

According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.

Healthcare stocks rally up to 8% as Covid cases spurt in China, Japan

Reports suggest that Union Health Minister Mansukh Mandaviya will review the Covid-19 pandemic situation, in view of a spurt in COVID-19 cases in Japan, South Korea, Brazil, China and the US.

Sun Pharma slips nearly 4% as USFDA issues import alert on Halol facility

For the year ended March 31, 2022, supplies to the US market from the Halol facility accounted for approximately 3 per cent of the company's consolidated revenues.

Laurus Labs hits 52-week low, tanks 7% on margin concerns

Laurus has witnessed severe pricing pressure and lower volumes in its ARV formulations portfolio for five quarters now, resulting in significant pressure on core margins, say analyst.

Stocks to Watch: Hero MotoCorp, Castrol, Tata Consumer, HFCL, Bikaji Foods

Stocks to Watch Today: Bikaji Foods, Castrol, Hero MotoCorp, Godrej Properties, Tat Consumer, pharma and insurance related shares are likely to be in focus on Monday.

Indoco Remedies hits 8-month high on hopes of margin boost; stock surges 7%

In the past one week, it rallied 17 per cent, as against 0.35 per cent rise in the S&P BSE Sensex

Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED

According to reports, ED has arrested Sarath Reddy, director of Aurobindo Pharma, under the money laundering act in the now scrapped Delhi Excise policy case.

HUL, GSK Asia to scrap distribution pact for OTC products by next year

In 2018, HUL had announced that GSK Consumer Healthcare will merge with HUL in an all-stock deal